161 related articles for article (PubMed ID: 33006547)
1. Growth Hormone Treatment and Papilledema: A Prospective Pilot Study.
Martín-Begué N; Mogas E; Wolley Dod C; Alarcón S; Clemente M; Campos-Martorell A; Fábregas A; Yeste D
J Clin Res Pediatr Endocrinol; 2021 Jun; 13(2):146-151. PubMed ID: 33006547
[TBL] [Abstract][Full Text] [Related]
2. Delayed onset of pseudotumor cerebri syndrome 7 years after starting human recombinant growth hormone treatment.
Vischi A; Guerriero S; Giancipoli G; Lorusso V; Sborgia G
Eur J Ophthalmol; 2006; 16(1):178-80. PubMed ID: 16496267
[TBL] [Abstract][Full Text] [Related]
3. Pseudotumor cerebri in children receiving recombinant human growth hormone.
Rogers AH; Rogers GL; Bremer DL; McGregor ML
Ophthalmology; 1999 Jun; 106(6):1186-9; discussion 1189-90. PubMed ID: 10366091
[TBL] [Abstract][Full Text] [Related]
4. Pseudopapilledema and congenital disc anomalies in growth hormone deficiency.
Collett-Solberg PF; Liu GT; Satin-Smith M; Katz LL; Moshang T
J Pediatr Endocrinol Metab; 1998; 11(2):261-5. PubMed ID: 9642641
[TBL] [Abstract][Full Text] [Related]
5. Headache, idiopathic intracranial hypertension and slipped capital femoral epiphysis during growth hormone treatment: a safety update from the KIGS database.
Darendeliler F; Karagiannis G; Wilton P
Horm Res; 2007; 68 Suppl 5():41-7. PubMed ID: 18174706
[TBL] [Abstract][Full Text] [Related]
6. Headache Characteristics in Children With Pseudotumor Cerebri Syndrome, Elevated Opening Pressure Without Papilledema, and Normal Opening Pressure: A Retrospective Cohort Study.
Hamedani AG; Witonsky KFR; Cosico M; Rennie R; Xiao R; Sheldon CA; Paley GL; McCormack SE; Liu GW; Friedman DI; Liu GT; Szperka CL
Headache; 2018 Oct; 58(9):1339-1346. PubMed ID: 30137653
[TBL] [Abstract][Full Text] [Related]
7. Achieving Optimal Short- and Long-term Responses to Paediatric Growth Hormone Therapy.
Wit JM; Deeb A; Bin-Abbas B; Al Mutair A; Koledova E; Savage MO
J Clin Res Pediatr Endocrinol; 2019 Nov; 11(4):329-340. PubMed ID: 31284701
[TBL] [Abstract][Full Text] [Related]
8. Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone.
Malozowski S; Tanner LA; Wysowski DK; Fleming GA; Stadel BV
J Pediatr; 1995 Jun; 126(6):996-9. PubMed ID: 7776116
[TBL] [Abstract][Full Text] [Related]
9. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
Whitman BY; Myers S; Carrel A; Allen D
Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
[TBL] [Abstract][Full Text] [Related]
10. Minocycline treatment and pseudotumor cerebri syndrome.
Chiu AM; Chuenkongkaew WL; Cornblath WT; Trobe JD; Digre KB; Dotan SA; Musson KH; Eggenberger ER
Am J Ophthalmol; 1998 Jul; 126(1):116-21. PubMed ID: 9683157
[TBL] [Abstract][Full Text] [Related]
11. Pseudotumor cerebri associated with lithium therapy in two patients.
Levine SH; Puchalski C
J Clin Psychiatry; 1990 Jun; 51(6):251-3. PubMed ID: 2347863
[TBL] [Abstract][Full Text] [Related]
12. An unexpected case of swollen optic nerves.
Hutcheon ML
Am J Ther; 2011 Jul; 18(4):e126-9. PubMed ID: 21519224
[TBL] [Abstract][Full Text] [Related]
13. Metabolic consequences of growth hormone treatment in paediatric practice.
Saenger P
Horm Res; 2000; 53 Suppl 1():60-9. PubMed ID: 10895045
[TBL] [Abstract][Full Text] [Related]
14. Probable pseudotumor cerebri complex in 25 children. Further support of a concept.
Tibussek D; Distelmaier F; Karenfort M; Harmsen S; Klee D; Mayatepek E
Eur J Paediatr Neurol; 2017 Mar; 21(2):280-285. PubMed ID: 27825557
[TBL] [Abstract][Full Text] [Related]
15. Approach to the Patient: Safety of Growth Hormone Replacement in Children and Adolescents.
Bamba V; Kanakatti Shankar R
J Clin Endocrinol Metab; 2022 Feb; 107(3):847-861. PubMed ID: 34636896
[TBL] [Abstract][Full Text] [Related]
16. Association between cycline antibiotic and development of pseudotumor cerebri syndrome.
Eldweik L; McClelland C; Stein JD; Blachley TS; Lee MS
J Am Acad Dermatol; 2019 Aug; 81(2):456-462. PubMed ID: 30905802
[TBL] [Abstract][Full Text] [Related]
17. Current indications for growth hormone therapy for children and adolescents.
Richmond E; Rogol AD
Endocr Dev; 2010; 18():92-108. PubMed ID: 20523020
[TBL] [Abstract][Full Text] [Related]
18. Deterioration of visual acuity associated with growth hormone therapy in a child with extreme short stature and high hypermetropia.
Paterson WF; Kelly B; Newman W; Savage MO; Camacho-Hubner C; Dutton GN; Tolmie J; Donaldson MD
Horm Res; 2007; 67(2):67-72. PubMed ID: 17028441
[TBL] [Abstract][Full Text] [Related]
19. [Intracranial hypertension and tetracycline therapy].
Iordănescu C
Oftalmologia; 1993; 37(2):152-3. PubMed ID: 8507628
[TBL] [Abstract][Full Text] [Related]
20. A Case Report of Pseudotumor Cerebri Syndrome with a Huge Retroperitoneal Cyst.
Kim JM; Kim H; Kang KW; Choi SM; Park MS
Medicina (Kaunas); 2023 Aug; 59(9):. PubMed ID: 37763692
[No Abstract] [Full Text] [Related]
[Next] [New Search]
